quinazolines has been researched along with chitosan in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Bhadury, PS; Hu, DY; Jin, LH; Lu, P; Song, BA; Xu, GF; Xue, W; Yang, S; Zhang, PQ | 1 |
| Bao, J; Dai, Z; Lan, Y; Tu, W; Wei, T; Zhao, B | 1 |
| Chang, J; Shi, Y; Su, C; Yang, G; Zhao, L | 1 |
| Feng, B; Liu, M; Shi, Y; Su, C; Yang, G; Yu, X; Zhao, L | 1 |
| Karimi, M; Mobasseri, R; Naderi-Manesh, H; Ramakrishna, S; Tian, L | 1 |
| Shi, Y; Su, C; Zhao, L; Zheng, Y | 2 |
| Abd El-Aziz, MF; Elnabarawi, MA; Ismail, S; Tadros, MI | 1 |
| Petkova, A; Schätzlein, AG; Soundararajan, R; Uchegbu, IF; Wang, G | 1 |
9 other study(ies) available for quinazolines and chitosan
| Article | Year |
|---|---|
Synthesis and antifungal activity of novel s-substituted 6-fluoro-4-alkyl(aryl)thioquinazoline derivatives.
Topics: Acetylglucosamine; Antifungal Agents; Cell Membrane; Chitinases; Chitosan; Fungi; Fusarium; Magnetic Resonance Spectroscopy; Mycelium; Permeability; Quinazolines; Spectrophotometry, Infrared; Sulfhydryl Compounds | 2007 |
Electrochemical monitoring of an important biomarker and target protein: VEGFR2 in cell lysates.
Topics: Animals; Biosensing Techniques; Cell Line; Chitosan; Electrochemical Techniques; Endothelial Cells; Graphite; Immunoassay; Macaca mulatta; Niacinamide; Oxidation-Reduction; Phenothiazines; Phenylurea Compounds; Piperidines; Protein Kinase Inhibitors; Quinazolines; Retina; Sorafenib; Vascular Endothelial Growth Factor Receptor-2 | 2014 |
Co-delivery of Gefitinib and chloroquine by chitosan nanoparticles for overcoming the drug acquired resistance.
Topics: Adenosine Triphosphate; Annexin A5; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Survival; Chitosan; Chloroquine; Drug Delivery Systems; Drug Resistance, Neoplasm; Endocytosis; Fluorescein-5-isothiocyanate; Gefitinib; Humans; Intracellular Space; Nanoparticles; Necrosis; Quinazolines | 2015 |
Intracellular targeted co-delivery of shMDR1 and gefitinib with chitosan nanoparticles for overcoming multidrug resistance.
Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Chitosan; Deoxyribonuclease I; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Electrophoresis, Agar Gel; Endocytosis; Flow Cytometry; Gefitinib; HeLa Cells; Humans; Intracellular Space; Nanoparticles; Neoplasms; Particle Size; Quinazolines; RNA, Small Interfering; Transfection | 2015 |
Hydrophobic lapatinib encapsulated dextran-chitosan nanoparticles using a toxic solvent free method: fabrication, release property & in vitro anti-cancer activity.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Chitosan; Dextrans; Drug Carriers; Drug Liberation; Dynamic Light Scattering; Humans; Hydrophobic and Hydrophilic Interactions; Lapatinib; Microscopy, Electron, Scanning; Nanoparticles; Particle Size; Quinazolines; Spectroscopy, Fourier Transform Infrared | 2017 |
Chitosan nanoparticle-mediated co-delivery of shAtg-5 and gefitinib synergistically promoted the efficacy of chemotherapeutics through the modulation of autophagy.
Topics: A549 Cells; Animals; Antineoplastic Agents; Apoptosis; Autophagy; Autophagy-Related Protein 5; Cell Line, Tumor; Chitosan; Drug Delivery Systems; Female; Gefitinib; Gene Silencing; Humans; Mice, Inbred BALB C; Mice, Nude; Nanomedicine; Nanoparticles; Neoplasms, Experimental; Quinazolines; RNA, Small Interfering; Transfection | 2017 |
mAb MDR1-modified chitosan nanoparticles overcome acquired EGFR-TKI resistance through two potential therapeutic targets modulation of MDR1 and autophagy.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Autophagy; Cell Line, Tumor; Chitosan; Chloroquine; Drug Delivery Systems; Drug Resistance, Neoplasm; ErbB Receptors; Gefitinib; Humans; Nanoparticles; Neoplasms; Protein Kinase Inhibitors; Quinazolines | 2017 |
Alfuzosin hydrochloride-loaded low-density gastroretentive sponges: development,
Topics: Abdomen; Adrenergic alpha-1 Receptor Antagonists; Biological Availability; Chitosan; Drug Carriers; Drug Compounding; Drug Delivery Systems; Drug Liberation; Drug Monitoring; Ferrosoferric Oxide; Gastric Mucosa; Healthy Volunteers; Humans; Hypromellose Derivatives; Magnetic Resonance Imaging; Porosity; Quinazolines; Solubility; Surface Properties | 2020 |
Hyaluronidase Coated Molecular Envelope Technology Nanoparticles Enhance Drug Absorption via the Subcutaneous Route.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Delivery Systems; Female; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Hyaluronoglucosaminidase; Hydrophobic and Hydrophilic Interactions; Hydroxamic Acids; Mice; Mice, Nude; Microscopy, Electron, Transmission; Nanoparticles; Particle Size; Polymers; Quinazolines; Rats; Solubility; Xenograft Model Antitumor Assays | 2020 |